Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” fourth quarter 2024 investor ...

Shares of Baxter International Inc. BAX slid 4.02% to $34.41 Wednesday, on what proved to be an all-around mixed trading ...

Baxter’s stock price fell to $36.42. Shareholders have lost 7.3% of their capital, which is disappointing considering the S&P ...

Baxter International Inc. closed 20.10% short of its 52-week high of $44.01, which the company reached on March 8th.

Baxter International on Thursday forecast 2025 profit above Wall Street estimates banking on strong sales of its medical devices, sending the company's shares up 7% in premarket trade.

Clinical teams working in hospitals are constantly on the move, keeping up with urgent demands in a fast-paced environment. | ...

Investors in Baxter International Inc (Symbol: BAX) saw new options become available today, for the June 2026 expiration. One of the key data points that goes into the price an option buyer is ...

Barclays analyst Matt Miksic maintained a Buy rating on Baxter International (BAX – Research Report) on March 7 and set a price target of ...

Barclays raised the firm’s price target on Baxter (BAX) to $41 from $39 and keeps an Overweight rating on the shares. The firm updated its ...

Revenue: US$10.6b (down 28% from FY 2023). Net loss: US$337.0m (loss widened by 343% from FY 2023). US$0.66 loss per share (further deteriorated from US$0.15 loss in FY 2023). Revenue was in line ...

For the quarter, the S&P 500® Index added 2.41%, while the MSCI EAFE Index slid 8.11%. Click here to read the full commentary ...